Veterinary Medicines

Nobivac L+DHPPi lyofilisaat en suspensie voor suspensie voor injectie voor honden

Authorised
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine distemper virus, strain Onderstepoort, Live
Download as PDF

Product identification

Medicine name:
Nobivac L+DHPPi lyofilisaat en suspensie voor suspensie voor injectie voor honden
Active substance:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine distemper virus, strain Onderstepoort, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated
    750.00
    unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
    1300.00
    unit(s)
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    10000.00
    unit(s)
    /
    1.00
    Dose
  • Canine parvovirus, strain 154, Live
    10000000.00
    unit(s)
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain Cornell, Live
    316228.00
    unit(s)
    /
    1.00
    Dose
  • Canine distemper virus, strain Onderstepoort, Live
    10000.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Nederland B.V.
Responsible authority:
  • MEB
Authorisation number:
  • REG NL 9483
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/07/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."